Apply Now

News » Archives » July 2014

Potential biomarker proves promising for pancreatic cancer diagnostics

Author: Katrina Burgos


When it comes to a cancer diagnosis, timing can be everything. An early diagnosis can make a big difference when it comes to treatment possibilities. Pancreatic Ductile Adenocarcinoma (PDAC) has a 5 year survival rate of 6% according to Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology at the University of Notre Dame. Improving detection rates is a crucial step in changing that statistic. Read more... Read More